Antihypertensive agents in systemic hypertension associated with Type 2 diabetes in a tertiary care hospital
Keywords:Hypertension, Antihypertensive agents, Diabetes, Joint National Committee 7
Background: Hypertension and diabetes mellitus are both chronic disorders and when they occur as co-morbidities create havoc by presenting with a plethora of morbidity and mortality. Both require drug treatment over a long period of time, which calls for stringent analysis of prescribing trends of the same.
Objectives: The present study was intended to analyze prescribing pattern and establish prescribing trends of anti-hypertensive drugs (AHD) in hypertensive diabetic patients.
Methods: The present study was a record based, randomized, non-interventional study of 2 years duration conducted at a tertiary care hospital of central India. Prescriptions from 400 case records of hypertensive diabetics were obtained from the medical record section. Demographic details, blood pressure, and AHDs prescribed were systematically entered in pre-validated case record form. All data were thoroughly analyzed for fallacies and appropriateness.
Results: Among 400 patients, 221 were males, and 179 were females. Monotherapy was used in 366 (91.5%) patients while combination therapy was used in 34 (8.5%) patients. Most commonly used combination was angiotensin converting enzyme inhibitor (ACEI)+calcium channel blocker (CCB), while in monotherapy CCB≥ACEI>beta blocker>diuretic>angiotensin II receptor blocker were most commonly prescribed.
Conclusion: The present study represents trend and attitude of physicians in prescribing AHDs. On comparing with Joint National Committee 7 guidelines, the majority of the cases deviated from the guidelines, mostly in a choice of AHDs and Fixed dose combination.
Kearney PM, Whelton M, Reynolds K, Muntner P, Whelton PK, He J. Global burden of hypertension: analysis of worldwide data. Lancet. 2005;365:217-23.
Singh RB, Suh IL, Singh VP, Chaithiraphan S, Laothavorn P, Sy RG, et al. Hypertension and stroke in Asia: prevalence, control and strategies in developing countries for prevention. J Hum Hypertens. 2000;14(10-11):749-63.
Triplitt CL, Reasner CA, Isley WL, et al. Pharmacotherapy: a Pathophysiologic Approach. 7th Edition. New York, NY: McGraw Hill Professional; 2008: 1285-320.
Rayappa PH, Raju KN, Kapur A, Bjork S, Sylvist C, Dilip. Economic cost of diabetes care the Bangalore urban district diabetes study. Int J Diabetes Dev Ctries. 1999;19:87-96.
Rampal L, Rampal S, Azhar MZ, Rahman AR. Prevalence, awareness, treatment and control of hypertension in Malaysia: a national study of 16,440 subjects. Public Health. 2008;122(1):11-8.
Simonson DC. Etiology and prevalence of hypertension in diabetic patients. Diabetes Care. 1988;11(10):821-7.
Kousalya K, Chirumamilla S, Manjunath S, Ramalakshmi S, Saranya P, Chamundeeswari D. Prescribing trend of antihypertensive drugs in hypertensive and diabetic hypertensive patients. Asian J Pharm Clin Res. 2012;5(4):22 3.
Bell DH. Stroke in the diabetic patient. Diabetes Care. 1994;17:213-9.
Patel V, Chatterji S, Chisholm D, Ebrahim S, Gopalakrishna G, Mathers C, et al. Chronic diseases and injuries in India. Lancet. 2011;377(9763):413-28.
Tanu M, Bhola N, Ranjeeta K, Rao YK, Pandey U. Prevalence of hypertension in India: a meta-analysis. World J Meta-Anal. 2013;1(2):83-9.
Gu Q, Paulose-Ram R, Dillon C, Burt V. Antihypertensive medication use among US adults with hypertension. 2006;113:213-21.
World Health Organisation. Teachers Guide to Good Prescribing. World Health Organization Department of Essential Drugs and Medicine Policy. Geneva: World Health Organization; 2001.
Chobanian AV, Bakris GL, Black HR, Cushman WC, Green LA, Izzo JL Jr, et al. The 7th report of the Joint National Committee on prevention, detection, evaluation, and treatment of high blood pressure: the JNC 7 report. JAMA. 2003;289:2560-72.
Sultana S, Hamid K, Islam KM, Roy S, Saha MR, Zulfiker AH, et al. Assessment of prescription pattern of hypertensive patient’s prescription. Eur J Sci Res. 2010;40(4):500-5.
Jassim al Khaja KA, Sequeira RP, Wahab AW, Mathur VS. Antihypertensive drug prescription trends at the primary health care centres in Bahrain. Pharmacoepidemiol Drug Saf. 2001;10(3):219-27.
Jeschke E, Ostermann T, Vollmar HC, Kröz M, Bockelbrink A, Witt CM, et al. Evaluation of prescribing patterns in a German network of CAM physicians for the treatment of patients with hypertension: a prospective observational study. BMC Fam Pract. 2009;10:78.
Pillay T, Smith AJ, Hill SR. A comparison of two methods for measuring anti-hypertensive drug use: concordance of use with South African standard treatment guidelines. Bull World Health Organ. 2009;87(6):466-71.
Kabir Z, Feely J, Bennett K. Primary care prescribing patterns in Ireland after the publication of large hypertension trials. Br J Clin Pharmacol. 2007;64(3):381-5.
Fretheim A. Back to thiazide-diuretics for hypertension: reflections after a decade of irrational prescribing. BMC Fam Pract. 2003;4:19.
World Health Organization. Introduction to Drug Utilization Research. Geneva: World Health Organization; 2003.
World Health Organization. WHO Model List of Essential Medicines. 17th Edition. Geneva: World Health Organization; 2011. March. Available at: http://www.who.int/medicines/publications/essentialmedicine/en/index.html. Accessed 06 February 2013.
Tripathi KD. Essentials of Pharmacology. 7th Edition. New Delhi: Jaypee Brothers Medical Publishers (P) Ltd; 2013: 957-61.
National High Blood Pressure Education Program Working Group Report on Hypertension in Diabetes. Hypertension. 1994;23(2):145-58.
Datta S, Udupa AL. Antihypertensive drug use in patients having comorbid diabetes: cross sectional prescription pattern study in a tertiary care hospital. Asian J Pharm Clin Res. 2010;3(4):43-5.
Sandozi T, Emani VK. Survey of prescription pattern of anti-hypertensive drugs in hypertensives and hypertension associated diabetics. Int J Pharm Bio Sci. 2010;1(4):23-26.
Tiwari H, Kumar A, Kulkarni SK. Prescription monitoring of anti-hypertensive drug utilisation at the Panjab University Health Centre in India. Singapore Med J. 2004;45(3):117-20.
Arief M, Harika B, Satyanarayana B. Evaluation of prescribing pattern of antihypertensive drugs in a tertiary care hospital. Acta Chim Pharm Indica. 2013;3(2):172-81.
Bhardwaj R, Kohli K, Kajal HL. A study of drug prescribing pattern and cost analysis among diabetic patients in a tertiary care teaching institute in North India. J Drug Deliv Ther. 2013;3(2):56-61.
Henriksen EJ, Jacob S, Kinnick TR, Youngblood EB, Schmit MB, Dietze GJ. ACE inhibition and glucose transport in insulinresistant muscle: roles of bradykinin and nitric oxide. Am J Physiol. 1999;277:R332-6.
American Diabetes Association. Nephropathy in diabetes. Diabetes Care. 2004;27:S79-83.
Lewis EJ, Hunsicker LG, Bain RP, Rohde RD. The effect of angiotensin-converting-enzyme inhibition on diabetic nephropathy. The collaborative study group. N Engl J Med. 1993;329:1456-62.
Hussain DZ, Sana A, Mohammed S, Razzaq MA. Patterns of drug therapy among diabetic hypertensive patients with other complications. Int J Pharm Pharm Sci. 2014;6(6):270 7.
Cheng SF, Hsu HH, Lee HS, Lin CS, Chou YC, Tien JH. Rational pharmacotherapy in the diabetic hypertension: analysis-prescribing patterns in a general hospital in Taiwan. J Clin Pharm Ther. 2004;29(6):547-58.
Jagadeesh KM, Kumar UR. Assessment of prescription pattern associated with anti hypertensive treatment at tertiary care teaching hospital in central Karnataka. Int J Sci Res. 2014;3(9):1481-3.
ter Wee PM, De Micheli AG, Epstein M. Effects of calcium antagonists on renal hemodynamics and progression of nondiabetic chronic renal disease. Arch Intern Med. 1994;154:1185-202.